Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 29, 2024

BUY
$775.18 - $881.7 $3,100 - $3,526
4 Added 400.0%
5 $4,000
Q4 2023

Feb 22, 2024

BUY
$775.18 - $881.7 $775 - $881
1 New
1 $0

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Scarborough Advisors, LLC Portfolio

Follow Scarborough Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scarborough Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scarborough Advisors, LLC with notifications on news.